May.08
11:43 AM ET
Tuesday, 8 May 2012
Ten days after the FDA sent warning letters to manufacturers of supplements with DMAA in it, the nation’s largest supplement retailers still have the product on the shelves. Read More
Sectors:Advertising
Companies:Vitamin Shoppe, Inc. | GNC Holdings
Apr.03
10:21 PM ET
Tuesday, 3 Apr 2012
Sharpen your pencils, it's Last Call quiz time. Read More
Topics:Employment | FDA | Technology | Newt Gingrich | Ron Paul | Rick Santorum | Mitt Romney | Elections | Politics and Government | Futures | Wall Street | Banking
Sectors:Pharmaceuticals | Automobiles | Technology | Media | Movies and Entertainment
Feb.27
5:08 PM ET
Monday, 27 Feb 2012
Vivus CEO Leland Wilson saw “a very powerful signal” that anti-obesity drug Qnexa would be approved. Read More
Feb.24
5:32 PM ET
Friday, 24 Feb 2012
Speculation has its place, but Cramer's researcher thinks there is lots of opportunity to profit from established companies, too. Read More
Topics:Patents | FDA | Stock Picks | Stock Market
Sectors:Biotechnology | Pharmaceuticals
Feb.23
7:15 PM ET
Thursday, 23 Feb 2012
What investors should take away from Vivus, as shares soar on FDA nod. Read More
Feb.23
1:53 PM ET
Thursday, 23 Feb 2012
Jon Najarian saw unusual activity in Vivus before its announcement Thursday regarding FDA approval. Read More
VIDEO | TOPIC : Politics and Government/Government Agencies/FDA
Chris Viehbacher, CEO, Sanofi says the firm has been built so that it could grow without having to rely on the research ...
CNBC's Seema Mody reports on the latest details of the FDA advisory panel's review of Arena Pharmaceuticals' anti-obesit...
More VideosNews |
TOPIC : Politics and
Tuesday, 22 May 2012
Source: The New York Times
Wednesday, 2 May 2012
Posted By:
| Source: CNBC.com
Tuesday, 1 May 2012
Posted By:
| Source: CNBC.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
